重症哮喘患者呼吸内科联合治疗效果分析

Effect Analysis of Combined Treatment of Respiratory Medicine in Severe Asthma Patients

目的分析重症哮喘患者呼吸内科联合治疗效果。方法选取我院呼吸内科2016年10月—2018年4月收治的98例重症哮喘患者作为研究对象,平均分为对照组和观察组。对照组采用常规治疗,观察组采用联合治疗,比较两组的临床疗效和治疗前后各项血气指标水平。结果观察组的临床治疗总有效率明显高于对照组;在PaO_2、PaCO_2方面,治疗前观察组与对照组比较,差异无统计学意义(P> 0.05);治疗后,两组比较,观察组均要明显优于对照组,差异有统计学意义(P<0.05)。结论重症哮喘患者实施呼吸内科联合治疗,疗效显著,有利于改善患者的健康状况。

Objective To analyze the effect of combined treatment of respiratory medicine in severe asthma patients. Methods 98 severe asthma patients admitted to our department of respiratory medicine from October 2016 to April 2018 were selected as the research subjects, and were equally divided into the control group and the observation group. The control groupwas treated with conventional treatment, while the observation group was treated with combined therapy. The clinical efcacy and blood gas indexes of the two groups were compared. Results The total efective rate of clinical treatment in the observation group was significantly higher than that of the control group. In PaO2 and PaCO2, there was no signifcant diference between the observation group and the control group before the treatment （P 〉 0.05）. After the treatment, the observation group was signifcantly better than the control group, and the diference was statistically signifcant （P 〈 0.05）. Conclusion Combined treatment of respiratory medicine is efective in severe asthma patients. It is beneficial to improve the health status of patients.